Achieve Life Sciences, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Achieve Life Sciences, Inc. (ACHV) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $875.00 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2013-05-02
- Achieve Life Sciences, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2013-03-31 was $875.00K.
- Achieve Life Sciences, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2012-12-31 was $1.33M, a 23.97% decline year-over-year.
- Achieve Life Sciences, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2012-09-30 was $2.83M.
- Achieve Life Sciences, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2012-06-30 was $6.00K, a 98.74% decline year-over-year.
- Achieve Life Sciences, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2012 was $3.83M, a 64.93% increase from fiscal 2011.
- Achieve Life Sciences, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2011 was $2.32M.
- Achieve Life Sciences, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2010 was -$13.56M, a 211.15% decline from fiscal 2009.
- Achieve Life Sciences, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2009 was $12.20M.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2013-03-31 | $875.00K 10-Q · filed 2013-05-02 | $2.21M derived: sum of 2 quarters · filed 2013-05-02 | $5.04M derived: sum of 3 quarters · filed 2013-05-02 | $5.05M derived: sum of 4 quarters · filed 2013-05-02 |
| 2012-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $4.17M derived: sum of 2 quarters · filed 2013-03-07 | $4.17M derived: sum of 3 quarters · filed 2013-03-07 | $3.83M 10-K · filed 2013-03-07 |
| 2012-09-30 | $2.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $2.84M derived: sum of 2 quarters · filed 2012-11-08 | $2.50M 10-Q · filed 2012-11-08 | $4.25M derived: sum of 4 quarters · filed 2013-05-02 |
| 2012-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | -$334.00K 10-Q · filed 2012-08-02 | $1.42M derived: sum of 3 quarters · filed 2013-05-02 | $1.24M derived: sum of 4 quarters · filed 2013-05-02 |
| 2012-03-31 | -$340.00K 10-Q · filed 2013-05-02 | $1.41M derived: sum of 2 quarters · filed 2013-05-02 | $1.23M derived: sum of 3 quarters · filed 2013-05-02 | $1.71M derived: sum of 4 quarters · filed 2013-05-02 |
| 2011-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $1.57M derived: sum of 2 quarters · filed 2013-03-07 | $2.05M derived: sum of 3 quarters · filed 2013-03-07 | $2.32M 10-K · filed 2013-03-07 |
| 2011-09-30 | -$178.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $299.00K derived: sum of 2 quarters · filed 2012-11-08 | $572.00K 10-Q · filed 2012-11-08 | -$658.00K derived: sum of 4 quarters · filed 2013-03-07 |
| 2011-06-30 | $477.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $750.00K 10-Q · filed 2012-08-02 | -$480.00K derived: sum of 3 quarters · filed 2013-03-07 | -$24.00K derived: sum of 4 quarters · filed 2013-03-07 |
| 2011-03-31 | $273.00K 10-Q · filed 2012-05-03 | -$957.00K derived: sum of 2 quarters · filed 2013-03-07 | -$501.00K derived: sum of 3 quarters · filed 2013-03-07 | |
| 2010-12-31 | -$1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | -$774.00K derived: sum of 2 quarters · filed 2013-03-07 | -$13.56M 10-K · filed 2013-03-07 | |
| 2010-09-30 | $456.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$12.33M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | -$12.79M 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | $12.20M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |